Stanzin Spalkit

Stanzin Spalkit

Auto-generated profile, based on publicly available information

Stanzin Spalkit

Department of Radiology, All India Institute of Medical Sciences, New Delhi, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2025 in Mycoses
Verified
Journal Article
Closed access
AAAnuj Ajayababu
Anuj Ajayababu
VMVed Prakash Meena
Ved Prakash Meena
PSPrayas Sethi
Prayas Sethi
ASAmandeep Singh
Amandeep Singh
RJRanveer Singh Jadon
Ranveer Singh Jadon
ARANIMESH RAY
ANIMESH RAY

1 March 2026 in JCO Global Oncology
Verified
Journal Article
Closed access
DSDr Nihanthy D S
Dr Nihanthy D S
KSKinjal Singh
Kinjal Singh
SRSAMEER RASTOGI
SAMEER RASTOGI
NBNiranjan Biswal
Niranjan Biswal
ASAkash Singh
Akash Singh
SSStanzin Spalkit
Stanzin Spalkit
PURPOSE: Sarcomas exhibit clinicopathologic heterogeneity, leading to diagnostic and therapeutic uncertainty. This study assesses the clinical value of integrating targeted RNA-based next-generation sequencing (NGS) into a multidisciplinary sarcoma workflow to improve diagnosis, enable comprehensive molecular characterization, and inform personalized treatment strategies. METHODS: In this prospective single-center study, 68 patients with suspected or confirmed soft tissue sarcoma underwent RNA-based NGS using a 138-gene fusion panel, integrated within a multidisciplinary sarcoma framework. Genomic findings integrated with histopathology and immunohistochemistry for diagnostic reclassification and treatment changes. RESULTS: Of 70 patients advised RNA-based NGS, 68 (97.1%) were evaluable (median age, 38.5 years). Soft tissue sarcomas predominated (77.1%), with 67.1% presenting with advanced disease. Initial histology included 17 round cell sarcomas (RC), 19 undifferentiated sarcomas (US), and 34 other subtypes. Among evaluable RC cases (n = 16), NGS identified diagnostic fusions in 87.5%, enabling reclassification in 68.7% and treatment change in 18.7%. In US, fusions were detected in 21.1%, all reclassified, with treatment altered in 75%. In other subtypes, fusions were found in 48.4%, enabling reclassification in 39.3% and treatment impact in 21.2%. Nondiagnostic mutations (eg, TP53 , SLX4 , NF1 ) were observed in 47.4% of US and 18.2% of other subtypes. Potentially actionable variants ( KIT , PIK3CA ) were seen in 5.8%. Overall, RNA-NGS was clinically informative in 50%, refined diagnosis in 41.1%, and influenced treatment in 26.4% of patients. CONCLUSION: To our knowledge, this first-of-its-kind study highlights the clinical utility of integrating targeted RNA-based NGS into multidisciplinary sarcoma care, enabling diagnostic reclassification in 41.1% of cases most notably in round cell sarcomas with atypical morphology. Both canonical and rare fusions informed individualized therapy, reinforcing RNA-NGS as a pivotal tool for diagnostic refinement and precision oncology in sarcoma management.

23 January 2026 in European Journal of Cancer
Verified
Journal Article
Closed access
KSKinjal Singh
Kinjal Singh
SRSAMEER RASTOGI
SAMEER RASTOGI
ASAkash Singh
Akash Singh
SKSimran Kaur
Simran Kaur
SGShivanand Gamanagatti
Shivanand Gamanagatti
PTPuneet Tanwar
Puneet Tanwar

30 June 2026 in Journal of Ultrasonography
Verified
Journal Article
Open access
SSStanzin Spalkit
Stanzin Spalkit
SCShashank Chapala
Shashank Chapala
KSKAPIL SHIRODKAR
KAPIL SHIRODKAR
ASAnkit Shah
Ankit Shah
BSBipin Shah
Bipin Shah
RBRajesh Botchu
Rajesh Botchu
The genicular nerves are sensory nerves that innervate the knee joint, playing a crucial role in pain transmission. Because of their small size, they are frequently underappreciated and overlooked during routine ultrasound examinations. With the advent of high-resolution ultrasound, these nerves can be visualized directly, facilitating targeted interventions. A detailed understanding of genicular nerve anatomy, ultrasound landmarks, and characteristic imaging appearances has significant clinical implications for managing knee pain. Given the high prevalence of chronic knee pain due to osteoarthritis and post-operative conditions, ultrasound-guided genicular nerve blocks and radiofrequency ablation are increasingly utilized. Traditionally, genicular nerve procedures, targeting three nerves (the superomedial, superolateral, and inferome- dial genicular nerves), were performed under fluoroscopic guidance. However, ultrasound offers distinct advantages, including real-time visualization of soft tissues, the absence of radiation exposure, and precise targeting of anatomical locations using revised landmarks and Doppler signal. These advancements have enabled more comprehensive targeting of five nerves: the superomedial genicular nerve, superolateral genicular nerve, inferomedial genicular nerve, recurrent peroneal genicular nerve, and the infrapatellar branch of the saphenous nerve. Although ablation of the recurrent peroneal genicular nerve carries a risk of injury to the common peroneal nerve, potentially resulting in foot drop, precise localization through ultrasound-guidance may help mitigate this complication. This article provides a comprehensive review of genicular nerve anatomy, ultrasound techniques, and interventional approaches, emphasizing the clinical relevance of ultrasound-guided procedures for managing knee pain and diagnosing nerve pathologies.

10 December 2025 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
SBSoham Banerjee
Soham Banerjee
SSStanzin Spalkit
Stanzin Spalkit
AGAnkur Goyal
Ankur Goyal
SGShivanand Gamanagatti
Shivanand Gamanagatti